Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nedocromil sodium (Tilade)

L A Bartels, E Farrington

    Pediatric Nursing
    |July 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Nedocromil sodium is a safe asthma medication for mild to moderate cases. It may reduce corticosteroid use and improve symptom control, offering an alternative to other asthma treatments.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anticoagulation with warfarin in pediatrics.

    Pediatric nursing·2002
    Same author

    Pediatric nursing Humanitarian Award recipient offers hope to children with AIDS.

    Pediatric nursing·1999
    Same author

    Vigabatrin.

    Pediatric nursing·1998
    Same author

    Macrolide antibiotics.

    Pediatric nursing·1998
    Same author

    Influence of myocardial ischemia and reperfusion on beta-adrenoceptor subtype expression.

    Journal of cardiovascular pharmacology·1998
    Same author

    Fosphenytoin sodium: new drug to replace intravenous phenytoin sodium.

    Pediatric nursing·1997

    Area of Science:

    • Pharmacology
    • Respiratory Medicine

    Background:

    • Nedocromil sodium is an antiasthmatic agent.
    • It is indicated for mild or moderate asthma not controlled by other medications.

    Purpose of the Study:

    • To evaluate nedocromil sodium as an alternative maintenance therapy for asthma.
    • To compare its efficacy with other asthma treatments.

    Main Methods:

    • Clinical studies were reviewed.
    • Efficacy of nedocromil sodium was compared to placebo and other asthma medications.

    Main Results:

    • Nedocromil sodium is well-tolerated and effective for mild to moderate asthma.
    • It may reduce the need for corticosteroids and improve symptom control.
    • Few studies have directly compared nedocromil sodium with cromolyn sodium.

    Conclusions:

    • Nedocromil sodium is a viable option for asthma management.
    • Further research is needed to define its role in pediatric asthma treatment.
    • Comparison studies with cromolyn sodium are required.